The emergence of high-throughput protein quantification methodologies has enabled the comprehensive characterization by longitudinal and cross-sectional studies of biological fluids under physiological and pathological conditions. In particular, the simultaneous investigation of cytokines and growth factors signaling pathways and their associated downstream effectors by integrated multiplexed approaches offers a powerful strategy to gain insights into biological networks and processes in living systems. A growing body of research indicates that bioactive molecules of human reproductive fluids, including human follicular fluid (hFF), may affect oocyte quality, fertilization and embryo development, thus potentially influencing the physiopathology of pregnancy-related conditions. In this work, an iTRAQ labeling strategy has been complemented with a multiplexed protein array approach to analyze hFFs with the aim to investigate biological processes and pathways related to in vitro fertilization (IVF) outcome. The iTRAQ labeling strategy lead to the quantification of 89 proteins, 30 of which were differentially expressed in hFFs with successful compared to unsuccessful IVF outcome. The targeted study, based on multiplexed antibody protein arrays, allowed the simultaneous quantification of 27 low abundance proteins, including growth factors, chemokines and cytokines endowed with pro- and anti-inflammatory activity. A significant number of differentially regulated proteins were involved in biological functions related to blood coagulation, acute phase response signaling and complement system. Overall, the present results provide an integrated overview of protein changes in hFFs associated to IVF outcome, thus improving current knowledge in reproductive medicine and fertility research.
References
[1]
Gadher SJ, Jarkovska K, Kovarova H (2009) Reproductive therapies and a need for potential biomarkers for prognostic and diagnostic screening of women desperate to conceive. Expert Rev Proteomics 6: 591-593. doi:10.1586/epr.09.79. PubMed: 19929604.
[2]
Kolialexi A, Mavrou A, Spyrou G, Tsangaris GT (2008) Mass spectrometry-based proteomics in reproductive medicine. Mass Spectrom Rev 27: 624-634. doi:10.1002/mas.20181. PubMed: 18618655.
[3]
Kolialexi A, Mavrou A, Tsangaris GT (2007) Proteomic analysis of human reproductive fluids. Proteomics Clin Appl 1: 853-860. doi:10.1002/prca.200700040. PubMed: 21136739.
[4]
Revelli A, Delle Piane L, Casano S, Molinari E, Massobrio M et al. (2009) Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics. Reprod Biol Endocrinol 7: 40-52. doi:10.1186/1477-7827-7-40. PubMed: 19413899.
[5]
Fortune JE (1994) Ovarian follicular growth and development in mammals. Biol Reprod 50: 225-232. doi:10.1095/biolreprod50.2.225. PubMed: 8142540.
[6]
Anahory T, Dechaud H, Bennes R, Marin P, Lamb NJ et al. (2002) Identification of new proteins in follicular fluid of mature human follicles. Electrophoresis 23: 1197-1202. doi:10.1002/1522-2683(200204)23:7/8. PubMed: 11981869.
[7]
Lee HC, Lee SW, Lee KW, Lee SW, Cha KY et al. (2005) Identification of new proteins in follicular fluid from mature human follicles by direct sample rehydration method of two-dimensional polyacrylamide gel electrophoresis. J Korean Med Sci 20: 456-460. doi:10.3346/jkms.2005.20.3.456. PubMed: 15953869.
[8]
Angelucci S, Ciavardelli D, Di Giuseppe F, Eleuterio E, Sulpizio M et al. (2006) Proteome analysis of human follicular fluid. Biochim Biophys Acta 1764: 1775-1785. doi:10.1016/j.bbapap.2006.09.001. PubMed: 17067859.
[9]
Liu AX, Zhu YM, Luo Q, Wu YT, Gao HJ et al. (2007) Specific peptide patterns of follicular fluids at different growth stages analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Biochim Biophys Acta 1770: 29-38. doi:10.1016/j.bbagen.2006.06.017. PubMed: 16949757.
[10]
Hanrieder J, Nyakas A, Naessén T, Bergquist J (2008) Proteomic analysis of human follicular fluid using an alternative bottom-up approach. J Proteome Res 7: 443-449. doi:10.1021/pr070277z. PubMed: 18047273.
[11]
Schweigert FJ, Gericke B, Wolfram W, Kaisers U, Dudenhausen JW (2006) Peptide and protein profiles in serum and follicular fluid of women undergoing IVF. Hum Reprod 21: 2960-2968. doi:10.1093/humrep/del257. PubMed: 16893915.
[12]
Bianchi L, Gagliardi A, Campanella G, Landi C, Capaldo A et al. (2013) A methodological and functional proteomic approach of human follicular fluid en route for oocyte quality evaluation. J Proteomics. doi:10.1016/j.jprot.2013.1002.1025.
[13]
Twigt J, Steegers-Theunissen RP, Bezstarosti K, Demmers JA (2012) Proteomic analysis of the microenvironment of developing oocytes. Proteomics 12: 1463-1471. doi:10.1002/pmic.201100240. PubMed: 22589193.
[14]
Kim YS, Kim MS, Lee SH, Choi BC, Lim JM et al. (2006) Proteomic analysis of recurrent spontaneous abortion: Identification of an inadequately expressed set of proteins in human follicular fluid. Proteomics 6: 3445-3454. doi:10.1002/pmic.200500775. PubMed: 16637005.
[15]
Jarkovska K, Martinkova J, Liskova L, Halada P, Moos J et al. (2010) Proteome mining of human follicular fluid reveals a crucial role of complement cascade and key biological pathways in women undergoing in vitro fertilization. J Proteome Res 9: 1289-1301. doi:10.1021/pr900802u. PubMed: 20058866.
[16]
Kushnir MM, Naessén T, Wanggren K, Rockwood AL, Crockett DK et al. (2012) Protein and steroid profiles in follicular fluid after ovarian hyperstimulation as potential biomarkers of IVF outcome. J Proteome Res 11: 5090-5100. doi:10.1021/pr300535g. PubMed: 22988950.
[17]
Gluck F, Hoogland C, Antinori P, Robin X, Nikitin F et al. (2013) EasyProt-an easy-to-use graphical platform for proteomics data analysis. J Proteomics 79: 146-160. doi:10.1016/j.jprot.2012.12.012. PubMed: 23277275.
[18]
Farina A, D'Aniello C, Severino V, Hochstrasser DF, Parente A et al. (2011) Temporal proteomic profiling of embryonic stem cell secretome during cardiac and neural differentiation. Proteomics 11: 3972-3982. doi:10.1002/pmic.201100063. PubMed: 21770033.
[19]
Rocco M, Malorni L, Cozzolino R, Palmieri G, Rozzo C et al. (2011) Proteomic profiling of human melanoma metastatic cell line secretomes. J Proteome Res 10: 4703-4714. doi:10.1021/pr200511f. PubMed: 21815687.
[20]
Severino V, Farina A, Chambery A (2013) Analysis of secreted proteins. Methods Mol Biol 1002: 37-60. doi:10.1007/978-1-62703-360-2_4. PubMed: 23625393.
[21]
Huang da W, Sherman BT, Lempicki RA (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13. doi:10.1093/nar/gkp505. PubMed: 19033363.
[22]
Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57. PubMed: 19131956.
[23]
Kingsmore SF (2006) Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat Rev Drug Discov 5: 310-320. doi:10.1038/nrd2006. PubMed: 16582876.
[24]
Melton L (2004) Protein arrays: proteomics in multiplex. Nature 429: 101-107. doi:10.1038/429101b. PubMed: 15129287.
[25]
Blaber SP, Webster RA, Hill CJ, Breen EJ, Kuah D et al. (2012) Analysis of in vitro secretion profiles from adipose-derived cell populations. J Transl Med 10: 172-187. doi:10.1186/1479-5876-10-172. PubMed: 22913454.
[26]
Li H, Li G, Zhao X, Wu Y, Ma W et al. (2013) Complementary serum proteomic analysis of autoimmune hepatitis in mice and patients. J Transl Med 11: 146-158. doi:10.1186/1479-5876-11-146. PubMed: 23763817.
[27]
Overgaard AJ, Thingholm TE, Larsen MR, Tarnow L, Rossing P et al. (2010) Quantitative iTRAQ-Based Proteomic Identification of Candidate Biomarkers for Diabetic Nephropathy in Plasma of Type 1 Diabetic Patients. Clin Proteomics 6: 105-114. doi:10.1007/s12014-010-9053-0. PubMed: 21124997.
[28]
Celis JE, Moreira JM, Cabezón T, Gromov P, Friis E et al. (2005) Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions. Mol Cell Proteomics 4: 492-522. doi:10.1074/mcp.M500030-MCP200. PubMed: 15695426.
[29]
Richani K, Soto E, Romero R, Espinoza J, Chaiworapongsa T et al. (2005) Normal pregnancy is characterized by systemic activation of the complement system. J Matern Fetal Neonatal Med 17: 239-245. doi:10.1080/14767050500072722. PubMed: 16147832.
[30]
Ricklin D, Hajishengallis G, Yang K, Lambris JD (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11: 785-797. doi:10.1038/ni.1923. PubMed: 20720586.
[31]
Ehrnthaller C, Ignatius A, Gebhard F, Huber-Lang M (2011) New insights of an old defense system: structure, function, and clinical relevance of the complement system. Mol Med 17: 317-329. PubMed: 21046060.
[32]
Ghebrehiwet B, Silverberg M, Kaplan AP (1981) Activation of the classical pathway of complement by Hageman factor fragment. J Exp Med 153: 665-676. doi:10.1084/jem.153.3.665. PubMed: 7252410.
[33]
Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA et al. (2006) Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 12: 682-687. doi:10.1038/nm1419. PubMed: 16715088.
[34]
de Agostini AI, Dong JC, de Vantéry Arrighi C, Ramus MA, Dentand-Quadri I et al. (2008) Human follicular fluid heparan sulfate contains abundant 3-O-sulfated chains with anticoagulant activity. J Biol Chem 283: 28115-28124. doi:10.1074/jbc.M805338200. PubMed: 18669628.
[35]
Shimada H, Kasakura S, Shiotani M, Nakamura K, Ikeuchi M et al. (2001) Hypocoagulable state of human preovulatory ovarian follicular fluid: role of sulfated proteoglycan and tissue factor pathway inhibitor in the fluid. Biol Reprod 64: 1739-1745. doi:10.1095/biolreprod64.6.1739. PubMed: 11369603.
[36]
Gentry PA, Plante L, Schroeder MO, LaMarre J, Young JE et al. (2000) Human ovarian follicular fluid has functional systems for the generation and modulation of thrombin. Fertil Steril 73: 848-854. doi:10.1016/S0015-0282(99)00635-4. PubMed: 10731552.
[37]
Bungay SD, Gentry PA, Gentry RD (2006) Modelling thrombin generation in human ovarian follicular fluid. Bull Math Biol 68: 2283-2302. doi:10.1007/s11538-006-9115-7. PubMed: 16838084.
[38]
Levi M, van der Poll T, Büller HR (2004) Bidirectional relation between inflammation and coagulation. Circulation 109: 2698-2704. doi:10.1161/01.CIR.0000131660.51520.9A. PubMed: 15184294.
[39]
Büscher U, Chen FC, Kentenich H, Schmiady H (1999) Cytokines in the follicular fluid of stimulated and non-stimulated human ovaries; is ovulation a suppressed inflammatory reaction? Hum Reprod 14: 162-166. doi:10.1093/humrep/14.suppl_1.162. PubMed: 10374114.
[40]
Lédée N, Gridelet V, Ravet S, Jouan C, Gaspard O et al. (2013) Impact of follicular G-CSF quantification on subsequent embryo transfer decisions: a proof of concept study. Hum Reprod 28: 406-413. doi:10.1093/humrep/des354. PubMed: 23223438.
[41]
Chaouat G, Dubanchet S, Ledée N (2007) Cytokines: Important for implantation? J Assist Reprod Genet 24: 491-505. doi:10.1007/s10815-007-9142-9. PubMed: 18044017.
[42]
Sarapik A, Velthut A, Haller-Kikkatalo K, Faure GC, Béné MC et al. (2011) Follicular proinflammatory cytokines and chemokines as markers of IVF success. Clin Dev Immunol 2012: 606459. doi:10.1155/2012/606459. PubMed: 22007253.
[43]
Hammadeh ME, Ertan AK, Zeppezauer M, Baltes S, Georg T et al. (2002) Immunoglobulins and cytokines level in follicular fluid in relation to etiology of infertility and their relevance to IVF outcome. Am J Reprod Immunol 47: 82-90. doi:10.1034/j.1600-0897.2002.1o024.x. PubMed: 11900592.
[44]
Gorospe WC, Spangelo BL (1993) Interleukin-6 production by rat granulosa cells in vitro: effects of cytokines, follicle-stimulating hormone, and cyclic 3',5'-adenosine monophosphate. Biol Reprod 48: 538-543. doi:10.1095/biolreprod48.3.538. PubMed: 7680907.
[45]
Terranova PF (1997) Potential roles of tumor necrosis factor-alpha in follicular development, ovulation, and the life span of the corpus luteum. Domest Anim Endocrinol 14: 1-15. doi:10.1016/S0739-7240(96)00094-X. PubMed: 8985665.
[46]
Terranova PF, Rice VM (1997) Review: cytokine involvement in ovarian processes. Am J Reprod Immunol 37: 50-63. doi:10.1111/j.1600-0897.1997.tb00192.x. PubMed: 9138453.
[47]
Mendoza C, Ruiz-Requena E, Ortega E, Cremades N, Martinez F et al. (2002) Follicular fluid markers of oocyte developmental potential. Hum Reprod 17: 1017-1022. doi:10.1093/humrep/17.4.1017. PubMed: 11925399.
